MedPath

Nutrient And Non-Nutrient Intake, Relative Biomarkers and Their Health Effects In Apparently Healthy Participants

Active, not recruiting
Conditions
Participants With/Without Risk Factors for Metabolic Diseases
Registration Number
NCT07110805
Lead Sponsor
University of Milan
Brief Summary

This observational study aims to provide a comprehensive evaluation of dietary habits, physical activity, biomarkers involved in nutrition, metabolic and inflammatory status as well as intestinal permeability in apparently healthy volunteers aged over 18 years working or studying at the University of Milan. Furthermore, the analysis of the gut microbiota composition along with the omics approaches will be crucial for a better comprehension of the relationship between diet and health status in this population. As part of the OnFoods project (Project code PE00000003, Concession Decree No. 1550 of 11 October 2022 adopted by the Italian Ministry of University and Research, CUP D93C22000890001, Project title "ON Foods - Research and innovation network on food and nutrition Sustainability, Safety and Security - Working ON Foods"), the results will be valuable for suggesting targeted dietary and behavioral guidance in the context of public health policies.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Apparently healthy volunteers
  • age ≥ 18 years old
Exclusion Criteria
  • Pregnancy or breastfeeding
  • not willing to sign informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dietary intake assessmentAt baseline and in 1 month

Two repeated 24h recalls performed at least 3 weeks apart will be used to assess energy, nutrient and non-nutrient intake.

Secondary Outcome Measures
NameTimeMethod
AnthropometryAt baseline

Anthropometric measures including weight (in kilograms) and height (in meters) will be measured and combined to report body mass index (BMI) in kg/m\^2.

Assessment of fat free mass and fat massAt baseline

Bio-Impendence Analysis (BIA) was used to assess fat free mass (FFM) in kg and fat mass (FM) in kg.

Bioelectrical phase angleAt baseline

Bio-Impendence Analysis (BIA) was used to measure phase angle in degree.

MediLite to assess adherence to Mediterranean DietAt baseline

The questionnaire consists of 9 items assessing the daily consumption of fruit, vegetables, cereals, meat and meat products, dairy products, alcohol, and olive oil, and the weekly consumption of legumes and fish. Each item provides a score ranging from 0 to 2 points. The final score ranges from 0 (low adherence) to 18 (high adherence to the Mediterranean diet).

MEDAS to assess adherence to Mediterranean DietAt baseline

The questionnaire consists of 14 items evaluating the consumption of olive oil for cooking and dressing; daily intake of vegetables, fruits, butter and red meat; weekly intake of wine, legumes, fish, nuts, sweets, pastries or sugar-sweetened beverages; intake of white meat instead of red or processed red meat and the use of "sofrito" sauce. Each item provides a score ranging from 0 to 1 point. The final score ranges from 0 (low adherence) to 14 (high adherence to the Mediterranean diet).

Assessment of physical activity levelAt baseline

The short form of the International Physical Activity Questionnaire (IPAQ) consists of 7 items, exploring the intensity of physical activity based on metabolic equivalent of task (MET) consumption and sedentary behavior.

Assessment of food consumption based on NOVA classificationAt baseline

The NFFQ (NOVA food frequency questionnaire) consists of 94-item grouped in 9 sections headings: (1) fruit and nuts, (2) vegetables and legumes, (3) cereals and tubers, (4) meat and fish, (5) milk, dairy products, and eggs, (6) oils, fats, and seasonings, (7) sweets and sweeteners, (8) beverages and (9) other. Data are reported as g/day and total daily intake for each NOVA category.

Markers of nutritional statusAt baseline

Serum proteins involved in the assessment of nutritional status including albumin in mg/L and transferrin in mg/L as well as serum iron in mg/L will be evaluated through standardized analytical methods.

Fasting glucose and lipid profileAt baseline

Markers involved in glucose and lipid metabolisms such as fasting glucose in mg/dl, total cholesterol in mg/dl, LDL-cholesterol in mg/dl, HDL-cholesterol in mg/dl and triglycerides in mg/dl will be evaluated in serum through standardized analytical methods.

Liver functionAt baseline

Markers involved in hepatic functions such as aspartate transaminase in U/L, alanine transaminase in U/L and gamma glutamyl transferase in U/L will be evaluated in serum through standardized analytical methods.

Renal functionAt baseline

Markers involved in renal functions including uric acid, azotemia and creatinine in mg/dl will be evaluated in serum through standardized analytical methods.

Vitamins A, E and carotenoidsAt baseline

Plasma vitamin A and vitamin E in µg/mL as well as bioactive compounds such as carotenoids in µg/mL will be evaluated through standardized analytical methods.

Vitamin DAt baseline

Plasma vitamin D in ng/mL will be evaluated through standardized analytical methods.

Vitamin B12 and folateAt baseline

Plasma vitamin B12 in ng/mL and folate in ng/mL will be evaluated through standardized analytical methods.

C-reactive proteinAt baseline

C-reactive protein in mg/L will be measured in serum through standardized analytical methods.

Markers of systemic inflammationAt baseline

Markers involved in the inflammatory status such as TNF-α in pg/mL, IL-6 in pg/mL will be measured in serum through ELISA kits.

Markers of intestinal permeabilityAt baseline

Intestinal permeability will be assessed by analyzing serum zonulin in ng/mL and ZO-1 in ng/mL using ELISA kits.

Marker of intestinal permeabilityAt baseline

Serum calprotectin in µg/mL and fecal calprotectin in µg/g will be analyzed.

Microbiota compositionAt baseline

Microbiota composition in fecal samples will be evaluated through 16S rRNA sequencing methods.

Proteomic analysisAt baseline

Proteomic will be performed on serum samples using Somascan.

Metabolomic analysisAt baseline

Metabolomic will be performed on urine samples by mass spectrometry.

Cellular DNA damageAt baseline

To assess damage at the cellular DNA level the Comet assay technique will be employed.

Trial Locations

Locations (1)

Division of Human Nutrition Department of Food, Environmental and Nutritional Sciences - DeFENS Università degli Studi di Milano

🇮🇹

Milan, Italy

Division of Human Nutrition Department of Food, Environmental and Nutritional Sciences - DeFENS Università degli Studi di Milano
🇮🇹Milan, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.